Osteocyte — A new target for the treatment of osteoporosis / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 627-630, 2013.
Artículo
en Chino
| WPRIM
| ID: wpr-437708
ABSTRACT
The osteocyte has been found to be an orchestrator of bone remodeling.The damage of bone leads to osteocyte apoptosis.Sclerostin secreted by osteocyte causes feedback inhibition of bone formation,so inhibition of sclerostin expression has become a new target of treatment for osteoporosis.It seems resonable to direct clinical practise and treatment of metabolic bone diseases through understanding the function of osteocyte in the process of bone remodeling.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Endocrinology and Metabolism
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS